Development of a novel acoustofluidic device for targeted antibody removal in pediatric organ transplant rejection
开发一种新型声流控装置,用于去除儿科器官移植排斥反应中的靶向抗体
基本信息
- 批准号:10372229
- 负责人:
- 金额:$ 24.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcousticsAddressAdultAllograftingAnimalsAntibodiesAntibody FormationAntibody TherapyAntigensAutoimmune DiseasesBiomedical EngineeringBloodBlood CellsBlood CirculationBlood Coagulation FactorBlood Component RemovalBlood PlateletsBlood TransfusionBlood VolumeBlood specimenCell SeparationCellsCellular StructuresCessation of lifeChildChildhoodCouplingDevelopmentDevicesDiseaseDoseEngineeringErythrocytesExcisionFailureFamily suidaeFutureGoalsGraft RejectionHLA AntigensHeart TransplantationHematologyHemorrhageHumanHypersensitivityHypotensionImmunityImmunologyIn VitroInfantInfectionInterdisciplinary StudyIsoantibodiesLeukocytesLifeLiquid substanceLongevityMediatingMethodsModelingMorbidity - disease rateMusNephrologyOrganOrgan TransplantationOrgan failurePatientsPharmaceutical PreparationsPhysiologicalPolystyrenesPositioning AttributePre-Clinical ModelPregnancyProcessProductionRattusRodentRodent ModelSafetySavingsSolidSpecificitySystemTechnologyTestingTimeTransfusionTranslatingTransplant RecipientsTransplant-Related DisorderTransplantationTreatment EfficacyUnited StatesWhole Bloodantibody-mediated rejectionbasecombatdesigndonor-specific antibodyeffective therapyfightinghemodynamicshigh riskin vivoin vivo Modelinnovationinstrumentmortalitynovelorgan transplant rejectionporcine modelpost-transplantpre-clinicalpreservationprototypesafety testingsoundtransplant model
项目摘要
ABSTRACT
Antibody-mediated diseases, including those associated with solid organ transplantation, are one of the top ten
causes of pediatric death. Over 50% of transplanted organs are lost by 10 years post-transplantation from
antibody-mediated rejection, which contributes significantly to the current organ shortage. The development of
antibodies to the transplanted organ occurs for various reasons including multiple blood transfusions, under
dosing of anti-rejection medications, previous transplants or pregnancy. These antibodies damage the
transplanted organ resulting in allograft failure and increased patient mortality. To overcome this limitation, using
a multi-disciplinary collaboration between transplant nephrology, biomedical engineering, immunology, and
hematology, we have developed an innovative approach for targeted antibody removal. Current therapies for
antibody-mediated rejection are not donor specific nor are they tailored toward children. Apheresis, one of the
standard therapies for antibody-mediated rejection, involves a machine for antibody removal that has been
developed for adults. The use of the current devices in children, however, is associated with multiple morbidities
including hypotension and the need for blood transfusions to maintain hemodynamic stability, which in turn
stimulates more antibody production. Additionally, infants are often ineligible for apheresis due to their small
size. Apheresis is also limited by non-specific antibody removal and significant antibody rebound. Lack of a
scalable apheresis machine precludes not only treatment of children with small blood volumes, but also limits
development of suitable pre-clinical models for testing safety and therapeutic efficacy. In prior studies, we show
that an acoustofluidic apheresis device is capable of using sound waves to efficiently separate antibody from
other cellular components such as red blood cells, white cells and platelets in small extracorporeal volumes (<20
mL) of whole blood and in sensitized rodent models. We have successfully developed antigen-specific beads to
capture donor antibodies in rodents. Our central hypothesis is that the innovative addition of trapping technology
will lead to more effective treatment of antibody-mediated rejection than current approaches by removing donor-
specific antibody more efficiently, preserving endogenous immunity and reducing antibody rebound. To achieve
this end, we will develop an antibody trapping method within an acoustofluidic device using piglet blood samples
with high levels of antibody. In parallel, we will examine an in vivo piglet sensitization model, where antibody
levels to donor antigens are extremely elevated. Our overall goal is to develop an acoustofluidic apheresis device
that removes the detrimental antibody specific to the transplanted organ and leaves behind beneficial antibodies
that fight infection. The ability to effectively treat antibody-mediated rejection will decrease pediatric mortality,
increase the life span of transplanted organs, and help alleviate organ shortages. The application of this novel
device will be paradigm shifting and directly translatable to children with solid organ transplantation, as well as
autoimmune disease, thus saving the lives of numerous children.
摘要
抗体介导的疾病,包括与实体器官移植相关的疾病,是十大疾病之一
儿科死亡的原因超过50%的移植器官在移植后10年内丢失,
抗体介导的排斥反应,这是导致目前器官短缺的重要原因。的发展
针对移植器官的抗体的产生有多种原因,包括多次输血,
抗排斥药物的剂量、既往移植或妊娠。这些抗体破坏了
移植器官导致同种异体移植失败和增加患者死亡率。为了克服这一限制,使用
移植肾脏学、生物医学工程、免疫学和
血液学,我们已经开发了一种创新的方法,有针对性的抗体去除。的现行疗法
抗体介导的排斥不是供体特异性的,也不是针对儿童的。单采术,
抗体介导的排斥反应的标准疗法,涉及一种用于去除抗体的机器,
为成人开发的。然而,在儿童中使用当前设备与多种发病率相关
包括低血压和需要输血以维持血流动力学稳定,
刺激更多的抗体产生。此外,由于婴儿的小,
尺寸单采还受到非特异性抗体去除和显著抗体反弹的限制。缺乏
可扩展的单采机不仅排除了对血容量小的儿童的治疗,
开发用于测试安全性和治疗功效的合适的临床前模型。在之前的研究中,我们发现
声流单采装置能够使用声波有效地将抗体从
其它细胞成分,如红细胞、白色细胞和血小板,在小的体外体积(<20
mL)的全血和致敏啮齿动物模型中。我们已经成功地开发了抗原特异性珠粒,
捕捉啮齿动物体内的供体抗体。我们的核心假设是,诱捕技术的创新性增加
将导致比目前的方法更有效的治疗抗体介导的排斥反应,
更有效地产生特异性抗体,保留内源性免疫力并减少抗体反弹。实现
为此,我们将开发一种使用仔猪血液样品的声流控装置内的抗体捕获方法
抗体水平很高同时,我们将研究体内仔猪致敏模型,其中抗体
供体抗原的水平非常高。我们的总体目标是开发一种声流分离装置
去除对移植器官有特异性的有害抗体,留下有益抗体
that fight战斗infection感染.有效治疗抗体介导的排斥反应的能力将降低儿科死亡率,
延长移植器官的寿命,帮助缓解器官短缺。这本小说的应用
该设备将是范式转移,并直接转移到儿童与实体器官移植,以及
自身免疫性疾病,从而挽救了许多儿童的生命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eileen Tsai Chambers其他文献
Eileen Tsai Chambers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eileen Tsai Chambers', 18)}}的其他基金
Development of a novel acoustofluidic device for targeted antibody removal in pediatric organ transplant rejection
开发一种新型声流控装置,用于去除儿科器官移植排斥反应中的靶向抗体
- 批准号:
10216827 - 财政年份:2021
- 资助金额:
$ 24.15万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 24.15万 - 项目类别:
Research Grant














{{item.name}}会员




